Dupuytren´s Disease Study. Primary Disease, MCP Joint, Xiapex, PNF

Status Completed

Clinical Trial Summary

Aim: Clinical RCT comparing functional results and recurrence rate following enzymatic treatment vs. needle aponeurotomy. Materials and methods: 30° or more contracture of only one metacarpophalangeal (MCP) joint contracture of one of the three ulnar digits and less than 20° for the adjacent proximal interphalangeal (PIP) joint. Patients with primary disease of the hand. Total of 80 patients needed to detect difference of 13.5°. 1) Needle aponeurotomy 2) Clostridium Histolyticum treatment. Clinical follow ups 1,4 weeks, 16 weeks and 1,2 and 5 years. Functional outcome scores: URAM, Quick Dash, EQ5D, brief MHQ, VAS pain and VAS patient satisfaction. Total passive extension contracture reduction, recurrence rate and registration of complications.

Clinical Trial Description

Open surgery (fascieectomy) has traditionally been considered the gold standard of treatment for Dupytren´s disease (Dd) despite considerable risk of complications. There is an increasing interest in Scandinavia in the treatment of Dd with Clostridium Histolyticum (Xiapex ®, Auxillium). However the enzyme is expensive and long-term effects are not well documented. More studies are needed to analyze both short and long term clinical outcome as well as cost-benefit analysis. The treatment arm of Xiapex in this study follows the recommendation as by the producer. The other treatment of Dd contracture in this study is needle fasiotomy/aponeurotomy. We use multiple perforation technigue with 26 G needle needle, with as little local anesthesia (xylocin w adrenaline) as needed during contionus extension of the finger untill successfully extended. The two procedures leave little scar tissue lessening the challenges posed by the reoperations. Recurrence rate of contracture following different treatments of Dupuytren's disease differs widely in the literature, and the rate is influenced by multiple factors. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02647619
Study type	Interventional
Source	University Hospital, Akershus
Contact
Status	Completed
Phase	Phase 4
Start date	October 2013
Completion date	April 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03155854` - The Effects of Prophylactic Limited Palmar Fasciectomy on Surgical Outcomes and Scarring	N/A
Active, not recruiting	`NCT03192020` - Trial Comparing Treatment Strategies in Dupuytren's Contracture	Phase 4
Recruiting	`NCT05300893` - Effectiveness of Night Splinting After Percutaneous Needle Fasciotomy in Dupuytren's Contracture	N/A
Recruiting	`NCT01184586` - Dupuytren's Disease and Extracorporeal Shockwave Therapy (DupuyShock-2010)	Phase 2
Recruiting	`NCT04122313` - Post-contracture Release Radiation for Dupuytren's Disease
Withdrawn	`NCT01776892` - Collagenase and Needle Aponeurotomy: Single Modality Versus Combination Treatment for Dupuytren's Disease	Phase 3
Completed	`NCT02983162` - Is wGRS Associated With DD Recurrence?
Completed	`NCT01923103` - Natural Disease Progress of Dupuytren Disease
Enrolling by invitation	`NCT03982719` - Comparing the Effectiveness of Two Post-fasciectomy Rehabilitation Protocols in Patients With Dupuytren's Disease	N/A
Not yet recruiting	`NCT04907812` - The Role of Tranexamic Acid in Reducing Post Operative Hand Edema After Hand and Wrist Surgery	Phase 4
Withdrawn	`NCT03031080` - BOND Study: the Benefit Of Night Splinting in Dupuytrens'	N/A
Active, not recruiting	`NCT04874870` - Effectiveness of Splinting After Collagenase Injection	Phase 3
Active, not recruiting	`NCT03407820` - Different Sutures in Hand Surgery	N/A
Recruiting	`NCT03000114` - Collagenase Injection vs Percutaneous Needle Aponeurotomy for Dupuytren's Disease	Phase 4
Recruiting	`NCT05440240` - Percutaneous Needle Fasciotomy +/- Corticosteroid Injection for Dupuytren's Contracture	Phase 4
Completed	`NCT03331926` - Collagenase is a Common Treatment of MCP and PIP Joint Contractures in Dupuytrens Disease
Active, not recruiting	`NCT03741764` - Treatment of Dupuytren's Disease With Minimal Invasive Surgery and VIVOSORB® Resorbable Implant Device	N/A
Completed	`NCT01876498` - Registry of Patient With M. Dupuytren and Validation of the Brief MHQ	N/A
Completed	`NCT03868449` - Question Prompt List for Common Hand Conditions	N/A
Completed	`NCT03573765` - Epidemiology and Outcomes of Upper Limb Surgery: Analysis of Routine Data